This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...